Since epidemiology is about associations, alternate explanations for the observed facts must always be explored. The scenario Professor de Wardener proposed must be tested for compatibility with the information in the original published article.
Since persistence in therapy and attainment of blood pressure control were similar across quartiles of sodium excretion, there is no reason to believe that the lowest quartile of urinary sodium patients differed in compliance behaviour. We also applied the standard method to test for completeness of urine collection. As it turned out, those in the lowest sodium quartile were no more likely to contribute an incomplete specimen than were subjects in any other sodium quartile. Moreover, when analysis was restricted to only those who provided appropriate collections, the strong inverse sodium to event relationship persisted. Finally, the sodium to event relationship was significant in a continuous fashion.
Since confounding requires that the explanatory factor influence both the exposure (urinary sodium), and the outcome (cardiovascular events), Dr de Wardener's hypothesis requires that non-compliant patients present urines that were continuously and inversely related to events.
There is, of course, another way in which compliance might have influenced this study. Subjects were advised to avoid high sodium foods for 5 days preceding urine collection. Perhaps, the most compliant subjects more vigorously avoided salty stuff to produce an unrepresentative lower sodium specimen. If that were the case, then the more favourable outlook generally enjoyed by compliant subjects worked against the inverse association of sodium to cardiovascular events actually seen. Thus, our estimate of the association of low sodium to CVD events may well be an under-estimate of the true association.
Epidemiology is a difficult process by which to establish causality. What is in contention in this observational study are not the facts, but their meaning. Optimally, as in our study, a hypothesis precedes data analysis.
Dr de Wardener believes that a low intake of sodium, presumably because it lowers blood pressure, will contribute to a longer or better life. The problem is that a low sodium diet has not just one, but multiple effects. It is the sum total of those effects that determines health consequences. Exclusive focus upon only one of these several demonstrated intermediate factors (plasma renin activity, sympathetic nerve activity, insulin resistance, or blood pressure) may, as Jeffrey Cutler has so elegantly put it, blind us to the totality of its effects. 3 The health effect of a low sodium diet can only be resolved by evidence that links human sodium intake to morbidity and mortality. The relevant published data, to our knowledge, is limited to three prospective observational studies.
2,4,5 They provide no evidence that a low sodium intake is beneficial, nor that a high sodium intake is harmful. Indeed, two of these three studies raise concerns about the safety of a low sodium intake.
The absence of any ecological, epidemiological, or experimental evidence that a low or reduced sodium diet extends or improves human life is an unusual basis upon which to recommend a sodium intake of 100 mmols/day for everyone. Fortunately, more than two dozen prospective population-based studies relating nutrition to morbidity and mortality are, or will soon be, complete. Public policy recommendations regarding sodium intake should be withheld until they can be justified by evidence.
